Novadiscovery
Marc Cikes has extensive experience in the healthcare and business sectors, currently serving as a Member of the Board of Directors for VivoSense, Inc., Novadiscovery, Aquamed SA, and Forum Managed Care Schweiz since 2023 and previously since 2014. As Managing Director at Debiopharm Innovation Fund S.A. since April 2023, Marc also holds the role of Chief Strategy Officer at DTECTIO, focusing on wearable ECG monitoring technology since October 2022. A Founding Partner of Medical Center Vaud SA and co-founder of Medbase Romandie, Marc has shared expertise as a Guest Lecturer at Université de Genève from September 2016 to June 2023. Marc's academic credentials include multiple certificates in business and healthcare management from prestigious institutions such as Columbia Business School, University of Lausanne, and Imperial College Business School, among others.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.